dockets: FDA-2019-P-3877

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2019-P-3877 FDA Requests that the FDA confirm the Reference Listed Drug (RLD), Glucophage®, NDA 020357 held by BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE was not withdrawn from sale for safety or effectiveness reasons. Nonrulemaking 2019-12-31T14:24:43Z 0b00006483e57a58   Open     ["Citizen Petition", "CDER", "Harman Finochem Limited", "Glucophage", "Metformin IR Tablets", "NDA 020357", "BRISTOL MYERSSQUIBB CO", "PHARMACEUTICAL RESEARCH INSTITUTE", "RLD", "Open"] CDER Requests that the FDA confirm the Reference Listed Drug (RLD), Glucophage®, NDA 020357 held by BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Citizen Petition", "CDER", "Harman Finochem Limited", "Glucophage", "Metformin IR Tablets", "NDA 020357", "BRISTOL MYERSSQUIBB CO", "PHARMACEUTICAL RESEARCH INSTITUTE", "RLD", "Open"], "modifyDate": "2019-12-31T14:24:43Z", "dkAbstract": "Open", "agencyId": "FDA", "program": "CDER", "shortTitle": "Requests that the FDA confirm the Reference Listed Drug (RLD), Glucophage\u00ae, NDA 020357 held by BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE", "subType2": null, "title": "Requests that the FDA confirm the Reference Listed Drug (RLD), Glucophage\u00ae, NDA 020357 held by BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE was not withdrawn from sale for safety or effectiveness reasons.", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b00006483e57a58"} single_get

Links from other tables